TTR Gene Amyloidosis Genetic Test
Cost: 4400.0 AED
Test Components:
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery:
3 to 4 Weeks
Method:
NGS Technology
Test Type:
Neurological Disorders
Doctor:
Neurologist
Test Department:
Genetics
Pre Test Information:
Clinical History of Patient who is going for TTR Gene Amyloidosis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TTR Gene Amyloidosis.
Test Details:
TTR gene amyloidosis is a rare genetic disorder that causes the abnormal buildup of amyloid protein in various organs and tissues of the body, leading to organ dysfunction and failure. This condition is caused by mutations in the TTR gene, which provides instructions for making a protein called transthyretin.
NGS (next-generation sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to rapidly and accurately analyze multiple genes at once. This type of testing can identify mutations in the TTR gene and other genes associated with amyloidosis, allowing for early diagnosis and personalized treatment plans.
NGS genetic testing for TTR gene amyloidosis typically involves a blood or saliva sample, which is analyzed in a specialized laboratory. Results are typically available within a few weeks and can provide valuable information for patients and their healthcare providers.
| Test Name | TTR Gene Amyloidosis Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TTR Gene Amyloidosis NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TTR Gene Amyloidosis |
| Test Details |
TTR gene amyloidosis is a rare genetic disorder that causes the abnormal buildup of amyloid protein in various organs and tissues of the body, leading to organ dysfunction and failure. This condition is caused by mutations in the TTR gene, which provides instructions for making a protein called transthyretin. NGS (next-generation sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to rapidly and accurately analyze multiple genes at once. This type of testing can identify mutations in the TTR gene and other genes associated with amyloidosis, allowing for early diagnosis and personalized treatment plans. NGS genetic testing for TTR gene amyloidosis typically involves a blood or saliva sample, which is analyzed in a specialized laboratory. Results are typically available within a few weeks and can provide valuable information for patients and their healthcare providers. |
